| 2024-05 |
Nuclear Localization of Yes-Associated Protein is Associated With Tumor Progression in Cutaneous Melanoma |
Laboratory Investigation
|
| 2023-11 |
Active involvement of patients, radiation oncologists, and surgeons in a multidisciplinary team approach: Guiding local therapy in recurrent, metastatic rectal cancer |
Cancer Medicine
|
| 2023-11 |
Atezolizumab plus Magrolimab, Niraparib, or Tocilizumab versus Atezolizumab Monotherapy in Platinum-Refractory Metastatic Urothelial Carcinoma: A Phase Ib/II Open-Label, Multicenter, Randomized Umbrella Study (MORPHEUS Urothelial Carcinoma) |
Clinical cancer research : an official journal of the American Association for Cancer Research
|
| 2023-11 |
A phase II study on the efficacy of regorafenib in treating patients with c-KIT-mutated metastatic malignant melanoma that progressed after previous treatment (KCSG-UN-14-13) |
European Journal of Cancer
|
| 2023-09 |
Effect of High-Versus Low-Frequency of Abdominopelvic Computed Tomography Follow-Up Testing on Overall Survival in Patients With Stage II Or III Colon Cancer |
Clinical Colorectal Cancer
|
| 2023-09 |
A Phase Ib, Open-label Study Evaluating the Safety and Efficacy of Ipatasertib plus Rucaparib in Patients with Metastatic Castration-resistant Prostate Cancer |
Clinical Cancer Research
|
| 2023-09 |
A prospective, multicenter study on the clinical effectiveness of abiraterone in metastatic castration-resistant prostate cancer in Korea: Pre- vs. post-chemotherapy |
Investigative and Clinical Urology
|
| 2023-08 |
Pembrolizumab Plus Olaparib for Patients With Previously Treated and Biomarker-Unselected Metastatic Castration-Resistant Prostate Cancer: The Randomized, Open-Label, Phase III KEYLYNK-010 Trial |
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
|
| 2023-08 |
Phase II study of a trastuzumab biosimilar in combination with paclitaxel for HER2-positive recurrent or metastatic urothelial carcinoma: KCSG GU18-18 |
ESMO Open
|
| 2023-07 |
Importance of Local Ablative Therapies for Lung Metastases in Patients With Colorectal Cancer |
Annals of Surgery
|
| 2023-07 |
Hepatic arterial infusion in combination with systemic chemotherapy in patients with hepatic metastasis from colorectal cancer: a randomized phase II study – (NCT05103020) – study protocol |
BMC Cancer
|
| 2023-07 |
Immunogenicity and Safety of Vaccines Against Coronavirus Disease in Actively Treated Patients with Solid Tumors: A Prospective Cohort Study |
Cancer Research and Treatment
|
| 2023-06 |
Short-Term Outcomes and Cost-Effectiveness between Long-Course Chemoradiation and Short-Course Radiotherapy for Locally Advanced Rectal Cancer |
Yonsei Medical Journal
|
| 2023-05 |
Mathematical prediction with pretreatment growth rate of metastatic cancer on outcomes: implications for the characterization of oligometastatic disease |
FRONTIERS IN ONCOLOGY
|
| 2023-03 |
Fusobacterium nucleatum induces a tumor microenvironment with diminished adaptive immunity against colorectal cancers |
Frontiers in cellular and infection microbiology
|
| 2023-02 |
Machine Learning-Based Mortality Prediction Model for Critically Ill Cancer Patients Admitted to the Intensive Care Unit (CanICU) |
Cancers
|
| 2023-01 |
Outcomes of an Acute Palliative Care Unit at a Comprehensive Cancer Center in Korea |
Palliative Medicine Reports
|
| 2022-12 |
A Comparison of 2 Disease Burden Assessment Methods (3D Volume Versus the Number of Lesions) for Prognostication of Survival in Metastatic Melanoma: Implications for the Characterization of Oligometastatic Disease |
International Journal of Radiation Oncology Biology Physics
|
| 2022-11 |
Oxaliplatin (3 months v 6 months) With 6 Months of Fluoropyrimidine as Adjuvant Therapy in Patients With Stage II/III Colon Cancer: KCSG CO09-07 |
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
|
| 2022-11 |
Feasibility of using dental putty-based custom molds for high-dose-rate brachytherapy of oral mucosal melanoma |
Physica Medica
|
| 2022-11 |
First-line pembrolizumab versus dabrafenib/trametinib treatment for BRAF V600–mutant advanced melanoma |
Journal of the American Academy of Dermatology
|
| 2022-10 |
The efficacy of immune checkpoint inhibitors in elderly patients: a meta-analysis and meta-regression |
Esmo Open
|
| 2022-08 |
Periodontal disease and cancer risk: A nationwide population-based cohort study |
Frontiers in Oncology
|
| 2022-07 |
The presence and size of intrahepatic tumors determine the therapeutic efficacy of nivolumab in advanced hepatocellular carcinoma |
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY
|
| 2022-07 |
KS10076, a chelator for redox-activemetal ions, induces ROS-mediated STAT3 degradation inautophagic celldeathandeliminatesALDH1+stemcells |
CELL REPORTS
|
| 2022-06 |
Application of Multigene Panel Testing in Patients With High Risk for Hereditary Colorectal Cancer: A Descriptive Report Focused on Genotype-Phenotype Correlation |
Diseases of the Colon and Rectum
|
| 2022-06 |
Metastasis-Directed Radiotherapy for Oligoprogressive or Oligopersistent Metastatic Colorectal Cancer |
CLINICAL COLORECTAL CANCER
|
| 2022-06 |
Tropomyosin-Related Kinase Fusions in Gastrointestinal Stromal Tumors |
Cancers
|
| 2022-05 |
Association of neutrophil-to-lymphocyte ratio, radiotherapy fractionation/technique, and risk of development of distant metastasis among patients with locally advanced rectal cancer |
RADIATION ONCOLOGY
|
| 2022-01 |
Suppression of DYRK1A/B Drives Endoplasmic Reticulum Stress-mediated Autophagic Cell Death Through Metabolic Reprogramming in Colorectal Cancer Cells |
ANTICANCER RESEARCH
|
| 2021-11 |
Upfront chemotherapy and short-course radiotherapy with delayed surgery for locally advanced rectal cancer with synchronous liver metastases |
EJSO
|
| 2021-11 |
Deep-Learning-Based Natural Language Processing of Serial Free-Text Radiological Reports for Predicting Rectal Cancer Patient Survival |
FRONTIERS IN ONCOLOGY
|
| 2021-10 |
Ferroportin and FBXL5 as Prognostic Markers in Advanced Stage Clear Cell Renal Cell Carcinoma |
CANCER RESEARCH AND TREATMENT
|
| 2021-09 |
Synthesis of novel 1H-Pyrazolo[3,4-b]pyridine derivatives as DYRK 1A/ 1B inhibitors |
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
|
| 2021-07 |
Patterns of Locoregional Recurrence after Radical Cystectomy for Stage T3-4 Bladder Cancer: A Radiation Oncologist's Point of View |
YONSEI MEDICAL JOURNAL
|
| 2021-07 |
Nationwide pharmacovigilance data for cetuximab-induced anaphylaxis and predictive model validation using prospective specific IgE detection |
World Allergy Organization Journal
|
| 2021-06 |
ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma |
NATURE
|
| 2021-05 |
The Awareness and Usage of Big Data for Cancer in Korea: A Survey Study |
보건정보통계학회지
|
| 2021-05 |
2020 Korean guidelines for the management of metastatic prostate cancer |
KOREAN JOURNAL OF INTERNAL MEDICINE
|
| 2021-05 |
Prediction of Immune-Checkpoint Blockade Monotherapy Response in Patients With Melanoma Based on Easily Accessible Clinical Indicators |
FRONTIERS IN ONCOLOGY
|
| 2021-03 |
Open-Label, Single-Arm, Phase II Study of Pembrolizumab Monotherapy as First-Line Therapy in Patients With Advanced Non-Clear Cell Renal Cell Carcinoma |
JOURNAL OF CLINICAL ONCOLOGY
|
| 2021-03 |
Autonomy is not but competence and relatedness are associated with physical activity among colorectal cancer survivors |
SUPPORTIVE CARE IN CANCER
|
| 2021-01 |
Role of Preoperative Chemoradiotherapy in Clinical Stage II/III Rectal Cancer Patients Undergoing Total Mesorectal Excision: A Retrospective Propensity Score Analysis |
FRONTIERS IN ONCOLOGY
|
| 2020-12 |
Clinical features and KRAS mutation in colorectal cancer with bone metastasis |
SCIENTIFIC REPORTS
|
| 2020-09 |
A Randomized Phase II Study of Perioperative Chemotherapy Plus Bevacizumab Versus Postoperative Chemotherapy Plus Bevacizumab in Patients With Upfront Resectable Hepatic Colorectal Metastases |
CLINICAL COLORECTAL CANCER
|
| 2020-09 |
Male sex and Breslow thickness are important risk factors for recurrence of localized melanoma in Korean populations |
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
|
| 2020-08 |
Clinical Significance of Preoperative Serum Carcinoembryonic Antigen Within the Normal Range in Colorectal Cancer Patients Undergoing Curative Resection |
ANNALS OF SURGICAL ONCOLOGY
|
| 2020-07 |
Clinical Outcomes of Immune Checkpoint Blocker Therapy for Malignant Melanoma in Korean Patients: Potential Clinical Implications for a Combination Strategy Involving Radiotherapy |
CANCER RESEARCH AND TREATMENT
|
| 2020-06 |
Objectively measured physical activity during chemotherapy in colon cancer patients |
SUPPORTIVE CARE IN CANCER
|
| 2020-04 |
Upfront radical surgery with total mesorectal excision followed by adjuvant FOLFOX chemotherapy for locally advanced rectal cancer (TME-FOLFOX): An open-label, multicenter, phase II randomized controlled trial |
TRIALS
|
| 2019-12 |
위장관암 환자의 옥살리플라틴 항암화학요법으로 인한 말초신경병증, 증상경험, 디스트레스와 삶의 질 |
Asian Oncology Nursing
|
| 2019-09 |
Effect of Radiotherapy Combined With Pembrolizumab on Local Tumor Control in Mucosal Melanoma Patients |
FRONTIERS IN ONCOLOGY
|
| 2019-06 |
Treatment Outcomes of Re-irradiation in Locoregionally Recurrent Rectal Cancer and Clinical Significance of Proper Patient Selection |
FRONTIERS IN ONCOLOGY
|
| 2019-03 |
Screening for Lung Cancer Using Low-dose Chest Computed Tomography in Korean Long-term Colorectal Cancer Survivors |
Journal of Cancer Prevention
|
| 2018-11 |
The role of endoscopic evaluation for radiation proctitis in patients receiving intermediate-dose postoperative radiotherapy for rectal cancer |
JAPANESE JOURNAL OF CLINICAL ONCOLOGY
|
| 2018-10 |
Genetic Alterations among Korean Melanoma Patients Showing Tumor Heterogeneity: A Comparison between Primary Tumors and Corresponding Metastatic Lesions. |
CANCER RESEARCH AND TREATMENT
|
| 2018-10 |
Prognoses and Clinical Outcomes of Primary and Recurrent Uveal Melanoma |
CANCER RESEARCH AND TREATMENT
|
| 2018-09 |
Activation of NKT Cells in an Anti-PD-1-Resistant Tumor Model Enhances Antitumor Immunity by Reinvigorating Exhausted CD8 T Cells. |
CANCER RESEARCH
|
| 2018-09 |
Predictive Nomogram for Recurrence of Stage I Colorectal Cancer After Curative Resection |
CLINICAL COLORECTAL CANCER
|
| 2018-07 |
CpG Island Methylator Phenotype and Methylation of Wnt Pathway Genes Together Predict Survival in Patients with Colorectal Cancer |
YONSEI MEDICAL JOURNAL
|
| 2018-06 |
IL21 Therapy Combined with PD-1 and Tim-3 Blockade Provides Enhanced NK Cell Antitumor Activity against MHC Class I-Deficient Tumors |
CANCER IMMUNOLOGY RESEARCH
|
| 2018-06 |
Mapping of lateral pelvic lymph node recurrences in rectal cancer: a radiation oncologist's perspective |
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
|
| 2018-03 |
YAP-Induced PD-L1 Expression Drives Immune Evasion in BRAFi-Resistant Melanoma |
CANCER IMMUNOLOGY RESEARCH
|
| 2017-12 |
A phase 1, open label, dose escalation study to investigate the safety, tolerability, and pharmacokinetics of MG1102 (apolipoprotein(a) Kringle V) in patients with solid tumors |
INVESTIGATIONAL NEW DRUGS
|
| 2017-10 |
Quality of life among Korean gastrointestinal cancer survivors |
EUROPEAN JOURNAL OF ONCOLOGY NURSING
|
| 2017-09 |
Role of adjuvant chemotherapy in locally advanced rectal cancer with ypT0-3N0 after preoperative chemoradiation therapy and surgery |
BMC CANCER
|
| 2017-08 |
Changes in telomerase activity due to alternative splicing of human telomerase reverse transcriptase in colorectal cancer |
ONCOLOGY LETTERS
|
| 2017-07 |
Reduced pelvic field sparing anastomosis for postoperative radiotherapy in selected patients with mid?upper rectal cancer |
JOURNAL OF RADIATION RESEARCH
|
| 2017-06 |
Oncogenic BRAF fusions in mucosal melanomas activate the MAPK pathway and are sensitive to MEK/PI3K inhibition or MEK/CDK4/6 inhibition. |
ONCOGENE
|
| 2017-06 |
IL-21-mediated reversal of NK cell exhaustion facilitates anti-Tumour immunity in MHC class I-deficient tumours |
NATURE COMMUNICATIONS
|
| 2017-01 |
Telomerase reverse transcriptase (TERT) promoter mutations in Korean melanoma patients |
AMERICAN JOURNAL OF CANCER RESEARCH
|
| 2017-01 |
Ipilimumab Real-World Efficacy and Safety in Korean Melanoma Patients from the Korean Named-Patient Program Cohort |
CANCER RESEARCH AND TREATMENT
|
| 2017-01 |
Preoperative Serum Carcinoembryonic Antigen Level as a Prognostic Factor for Recurrence and Survival After Curative Resection Followed by Adjuvant Chemotherapy in Stage III Colon Cancer |
ANNALS OF SURGICAL ONCOLOGY
|
| 2016-10 |
Dynamic Contrast-Enhanced Magnetic Resonance Imaging as a Surrogate Biomarker for Bevacizumab in Colorectal Cancer Liver Metastasis: A Single-Arm, Exploratory Trial |
CANCER RESEARCH AND TREATMENT
|
| 2016-09 |
High-risk clinicopathological features and their predictive significance in Korean patients with stage II colon cancer |
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
|
| 2016-08 |
Upfront Systemic Chemotherapy and Short-Course Radiotherapy with Delayed Surgery for Locally Advanced Rectal Cancer with Distant Metastases: Outcomes, Compliance, and Favorable Prognostic Factors |
PLOS ONE
|
| 2016-06 |
Impact of p16 expression in oropharyngeal cancer in the postoperative setting: the necessity of re-evaluating traditional risk stratification. |
JAPANESE JOURNAL OF CLINICAL ONCOLOGY
|
| 2016-06 |
Effects of microsatellite instability on recurrence patterns and outcomes in colorectal cancers |
BRITISH JOURNAL OF CANCER
|
| 2016-06 |
Comprehensive expression profiles of gastric cancer molecular subtypes by immunohistochemistry: Implications for individualized therapy |
ONCOTARGET
|
| 2016-03 |
Benefit of Adjuvant Chemotherapy After Curative Resection of Lung Metastasis in Colorectal Cancer |
ANNALS OF SURGICAL ONCOLOGY
|
| 2016-03 |
A New Practical Desensitization Protocol for Oxaliplatin-Induced Immediate Hypersensitivity Reactions: A Necessary and Useful Approach |
JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY
|